arrow
S

Seema Nagpal

Stanford Cancer Institute
H指数:36
被引数:5,431

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hormone receptor status switch and metastatic central nervous system tropism during breast cancer progression to leptomeningeal disease

乳腺癌进展至软脑膜病变过程中激素受体状态转换和转移性中枢神经系统趋向性

2026-10-090
OAAI
RMTC-10 DEFINING SYMPTOMATIC VERSUS ASYMPTOMATIC BRAIN METASTASES FOR CLINICAL TRIAL ELIGIBILITY: A DELPHI CONSENSUS INITIATIVE

RMTC-10 定义有症状与无症状脑转移用于临床试验入组资格:一项德尔菲共识倡议

2026-08-070
OA
TPRG-06 TRIAL IN PROGRESS: BRACER: EFFICACY AND SAFETY OF BEVACIZUMAB WHEN COMBINED WITH OTHER SYSTEMIC AGENTS IN THE TREATMENT OF BRAIN METASTASES RADIATION NECROSIS IN THE MODERN ERA

TPRG-06 试验进行中:BRACER:在当代背景下,与其他全身性药物联合使用时贝伐珠单抗治疗脑转移瘤放射性坏死的疗效与安全性

2026-08-070
OA
Phase 2 test of QBS72S for breast cancer leptomeningeal disease

QBS72S用于乳腺癌软脑膜疾病治疗的二期试验

2026-08-070
PRE
EVALUATION OF B7-H3 IMMUNOHISTOCHEMISTRY IN HIGH-GRADE GLIOMAS FOR CHIMERIC ANTIGEN RECEPTOR T-CELL PREDICTIVE TESTING

B7-H3免疫组织化学在高级别胶质瘤中用于嵌合抗原受体T细胞预测性检测的评价

2025-11-010
OAAI
BPM31510 engagement of the Warburg effect in GBM to therapeutically modulate tumor metabolism through ROS mediated processes preclinically and clinically

BPM31510通过Warburg效应在GBM中的参与,以在临床前和临床阶段通过ROS介导的过程治疗性调控肿瘤代谢。

2025-11-010
OAAI
LAT1 EXPRESSION SCALE AND ADAPTIVE DESIGN FOR A PHASE IIA TRIAL OF QBS72S IN BREAST CANCER BRAIN METASTASES

LAT1表达量表及QBS72S在乳腺癌脑转移IIA期试验中的适应性设计

2025-11-010
OAAI
SINGLE-CELL LANDSCAPE OF B7H3-CAR T THERAPY IN GLIOMA: MECHANISMS OF RESISTANCE AND SIGNATURES OF LONG-TERM RESPONSE

单细胞景观揭示B7H3-CAR T疗法在胶质瘤中的抗药机制及长期应答特征

2025-11-010
PRE
A novel therapeutic strategy using a single non-toxic agent that produces consistent long-term control of orthotopic experimental glioblastomas

一种使用单一非毒性制剂的新型治疗策略,可实现对正位实验性胶质母细胞瘤的持续长期控制

2025-11-010
OAAI
Phase 1 study of tumor treating fields concurrent with 5 day hypofractionated stereotactic radiosurgery with concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma..

I期研究:肿瘤治疗电场与5天低分割立体定向放射外科及同步辅助替莫唑胺联合治疗新诊断胶质母细胞瘤患者的疗效。

2025-11-010
OAAI
Trial in Progress (TiP): Interim analysis of a Phase 2 study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with Vitamin K in combination with Standard of Care (SOC) RT and TMZ in Glioblastoma Multiforme (GBM) patients without prior therapy

进行中试验(TiP):一项关于BPM31510(氧化辅酶Q10的脂质纳米分散体)联合维生素K,与标准护理(SOC)放疗(RT)和替莫唑胺(TMZ)联用治疗未经前期治疗的胶质母细胞瘤(GBM)患者的II期研究的期中分析

2025-11-010
OAAI
INTERIM ANALYSIS OF A PHASE IIA TRIAL OF LAT1-TARGETED QBS72S IN BREAST CANCER LEPTOMENINGEAL DISEASE

IIA期LAT1靶向QBS72S在乳腺癌脑膜疾病中的中期分析

2025-11-010
OAAI
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgery

重复立体定向放射手术治疗初次放射手术后局部复发的脑转移瘤

2025-09-070
PRE